EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced Taurine Serum Levels in Inflammatory Bowel Disease

Rachele Frascatani iD, Adelaide Mattogno, Andrea Iannucci iD, Irene Marafini, Giovanni Monteleone iD

Nutrients · 2024

DOI: 10.3390/nu16111593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Rachele Frascatani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy. Hauptthemen laut MEDLINE: Taurine, Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Taurine is a semi-essential micronutrient that acts as an anti-inflammatory molecule. The oral administration of taurine to colitic mice attenuates ongoing mucosal inflammation. This study aimed to determine whether inflammatory bowel diseases (IBDs) are marked by changes in the circulating levels of taurine. We measured the serum concentrations of taurine in 92 IBD patients [46 with ulcerative colitis (UC) and 46 with Crohn’s disease (CD)] and 33 healthy controls with a commercial ELISA kit. The taurine levels were significantly decreased in both patients with UC and patients with CD compared to the controls, while there was no difference between CD and UC. Taurine levels declined with age in healthy controls but not in IBDs. IBD patients younger than 50 years had levels of taurine reduced compared to their age-matched controls. In the IBD group, taurine levels were not influenced by the body mass index of the patients and the consumption of taurine-rich nutrients, while they were significantly reduced in UC patients with clinically active disease compared to those in clinical remission. These findings indicate that IBDs are marked by serum taurine deficiency, which would seem to reflect the activity of the disease, at least in UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TaurineColitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesHumansMaleFemaleMiddle AgedAdultCase-Control StudiesBody Mass IndexYoung AdultAged

Stichwörter der Autor:innen

Crohn’s diseaseIBDamino acidsulcerative colitis

Substanzen

Taurine

Autor:innen und Institutionen

  • Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
  • Policlinico Universitario Tor Vergata, 00133 Rome, Italy.
  • Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy.

ORCID-Profile: Rachele Frascatani, Andrea Iannucci, Giovanni Monteleone

Zitieren

APA

Frascatani, R., Mattogno, A., Iannucci, A., Marafini, I., & Monteleone, G. (2024). Reduced Taurine Serum Levels in Inflammatory Bowel Disease. Nutrients. https://doi.org/10.3390/nu16111593

Vancouver

Frascatani R, Mattogno A, Iannucci A, Marafini I, Monteleone G. Reduced Taurine Serum Levels in Inflammatory Bowel Disease. Nutrients. 2024. doi:10.3390/nu16111593

BibTeX
@article{Frascatani2024,
  author = {Frascatani, Rachele and Mattogno, Adelaide and Iannucci, Andrea and Marafini, Irene and Monteleone, Giovanni},
  title = {Reduced Taurine Serum Levels in Inflammatory Bowel Disease},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16111593}
}
Kostenlos starten →